Management of a patient diagnosed with ovarian cancer during pregnancy

封面


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

Insufficient diagnosis of ovarian tumors during pregnancy and decreased oncological alertness constitute huge problems that can subsequently have an unfavorable outcome for both the pregnant woman and the fetus. The difficulties of diagnosing and treating ovarian cancer during pregnancy were demonstrated on the following clinical case example. In pregnant patient A. at 19-20 weeks of pregnancy, a lesion was found in the area of the right appendages (100.9 × 55.4 × 93.4 mm, V = 273 cm3), with many tissue partitions and parietal tissue inclusions. The growth of the neoplasm was noted (CA-125 884 U / ml) and the pain syndrome occurred in the patient at 23-24 weeks of pregnancy. Magnetic resonance imaging revealed a solid-cystic neoplasm of the right ovary (cystadenoma?) and surgery was performed in November 2019. Based on the results of histological examination, a high-grade serous ovarian cancer was diagnosed without signs of microsatellite instability MSI-H/dMMR (in the right ovary, in the biopsy of the left fallopian tube). The patient. received two cycles of polychemotherapy (TC scheme). The treatment was tolerated satisfactorily (CA-125 287.3 U / ml). At a gestational age of 34 6/7 weeks (January 2020), a simultaneous operation was performed, including a lower midline laparotomy, a lower uterine segment caesarean section, extirpation of the uterus with appendages, and an omentectomy. A boy was born (weight 2280 g, height 44 cm) with the Apgar score of 7/7 points, with no complications noticed in the postpartum period. Postoperative histological examination showed metastasis of carcinoma in the left ovary with signs of therapeutic pathomorphosis. The treatment was completed in March 2020 after six cycles of polychemotherapy.

作者简介

Anna Protasova

V.A. Almazov National Medical Research Centre; Saint Petersburg State University; North-Western State Medical University named after I.I. Mechnikov; AVA-PETER Ltd.

编辑信件的主要联系方式.
Email: protasova1966@yandex.ru
SPIN 代码: 4097-0969

MD, Dr. Sci. (Med.), Professor

俄罗斯联邦, Saint Petersburg

Irina Zazerskaya

V.A. Almazov National Medical Research Centre

Email: zazera@mail.ru
SPIN 代码: 5683-6741

MD, Dr. Sci. (Med.)

俄罗斯联邦, Saint Petersburg

Anna Tsypurdeyeva

Saint Petersburg State University; AVA-PETER Ltd.; The Research Institute of Obstetrics, Gynecology, and Reproductology named after D.O. Ott

Email: tsypurdeeva@mail.ru
SPIN 代码: 5208-9707

MD, Cand. Sci. (Med.)

俄罗斯联邦, Saint Petersburg

Ekaterina Shelepova

V.A. Almazov National Medical Research Centre

Email: shelepowa@gmail.com
SPIN 代码: 9474-1351

MD, Cand. Sci. (Med.)

俄罗斯联邦, Saint Petersburg

Elena Vyshedkevich

V.A. Almazov National Medical Research Centre

Email: lenavish04@gmail.com
SPIN 代码: 5856-6500
俄罗斯联邦, Saint Petersburg

Inna Rizhinashvili

V.A. Almazov National Medical Research Centre

Email: innaenuk@gmail.com
俄罗斯联邦, Saint Petersburg

Alyona Sokolova

V.A. Almazov National Medical Research Centre

Email: alyona-sokolova@mail.ru
SPIN 代码: 2423-0370
俄罗斯联邦, Saint Petersburg

参考

  1. Leiserowitz GS, Xing G, Cress R, et al. Adnexal masses in pregnancy: how often are they malignant? Gynecol Oncol. 2006;101(2):315–321. doi: 10.1016/j.ygyno.2005.10.022
  2. Schmeler KM, Mayo-Smith WW, Peipert JF, et al. Adnexal masses in pregnancy: surgery compared with observation. Obstet Gynecol. 2005;105(5 Pt 1):1098–1103. doi: 10.1097/01.AOG.0000157465.99639.e5
  3. Smith LH, Dalrymple JL, Leiserowitz GS, et al. Obstetrical deliveries associated with maternal malignancy in California, 1992 through 1997. Am J Obstet Gynecol. 2001;184(7):1504–1513. doi: 10.1067/mob.2001.114867
  4. FIGO news. International Federation of Gynecology and Obstetrics. Treating cancer during pregnancy. [cited 2021 Apr 25]. Available from: https://www.figo.org/news/treating-cancer-during-pregnancy-0016145
  5. Goff BA, Mandel LS, Melancon CH, Muntz HG. Frequency of symptoms of ovarian cancer in women presenting to primary care clinics. JAMA. 2004;291(22):2705–2712. doi: 10.1001/jama.291.22.2705
  6. Goff BA, Mandel LS, Drescher CW, et al. Development of an ovarian cancer symptom index: possibilities for earlier detection. Cancer. 2007;109(2):221–227. doi: 10.1002/cncr.22371
  7. Palmer J, Vatish M, Tidy J. Epithelial ovarian cancer in pregnancy: a review of the literature. BJOG. 2009;116(4):480–491. doi: 10.1111/j.1471-0528.2008.02089.x
  8. Domini D, Campagna G, Coianiz A, et al. Mucinous adenocarcinoma of the ovary in pregnancy. Minerva Ginecol. 1999;51(3):99–101.
  9. Burke TW, Gershenson DM, Morris M, et al. Postoperative adjuvant cisplatin, doxorubicin, and cyclophosphamide (PAC) chemotherapy in women with high-risk endometrial carcinoma. Gynecol Oncol. 1994;55(1):47–50. doi: 10.1006/gyno.1994.1245
  10. ESMO European Society for Medical Oncology. ECC 2015 Press prelease: a cancer diagnosis while pregnant should not lead to treatment delay or pregnancy termination. [cited 2021 Apr 25]. Available from: https://www.esmo.org/Conferences/Past-Conferences/European-Cancer-Congress-2015/News/A-Cancer-Diagnosis-While-Pregnant-Should-Not-Lead-to-Treatment-Delay-or-Pregnancy-Termination

补充文件

附件文件
动作
1. JATS XML

版权所有 © Eсо-Vector, 2021



Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).